Statera Biopharma, Inc.
STABDelisted Mar 3, 2023- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001318641
Statera Biopharma, Inc. was delisted on Mar 3, 2023; its insiders filed their last Form 4 on Oct 28, 2021; 29 institutions reported holding it in 13F filings for Q4 2022, worth $197.5K in total; no superinvestor held it.
13F holders, Q1 2023
Institutional positions in Statera Biopharma, Inc. as of Mar 31, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
STAB is no longer listed, and 13F filings after Q4 2022 list far fewer holders. See Q4 2022
- Institutional holders
- 4
- −25 vs. Q4 2022
- Shares held
- 212.9K
- −2.26M (−91.4%) vs. Q4 2022
- Total value
- $3.29K
- −$194.2K (−98.3%) vs. Q4 2022
- New holders
- 0
- 0 more added
- Sold out
- 25
- 2 more reduced
Compare with Q4 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting STAB on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 0 | $0 |
| Q4 2025 | 0 | $0 |
| Q3 2025 | 0 | $0 |
| Q2 2025 | 0 | $0 |
| Q1 2025 | 0 | $0 |
| Q4 2024 | 1 | $0 |
| Q3 2024 | 1 | $0 |
| Q2 2024 | 1 | $1 |
| Q1 2024 | 1 | $1 |
| Q4 2023 | 1 | $1 |
| Q3 2023 | 1 | $0 |
| Q2 2023 | 1 | $30 |
| Q1 2023 | 4 | $3.29K |
| Q4 2022 | 29 | $197.5K |
| Q3 2022 | 35 | $383.3K |
| Q2 2022 | 35 | $894.9K |
| Q1 2022 | 33 | $669.2K |
| Q4 2021 | 29 | $4.64M |
| Q3 2021 | 23 | $2.81M |
| Q2 2021 | 21 | $4.31M |
| Q1 2021 | 22 | $5.61M |
Institutions, Q1 2023
Shares, value and share of portfolio for each institution holding Statera Biopharma, Inc.; share changes are against Q4 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Acadian Asset Management LLC | 211,836 | $3.00K | 0.00% | −223,026−51.3% | Reduced |
| IFP Advisors, Inc | 87 | $271 | 0.00% | −500−85.2% | Reduced |
| Tucker Asset Management LLC | 1,000 | $18 | 0.00% | 00.0% | Unchanged |
| Umb Bank N A | 5 | $0 | 0.00% | 00.0% | Unchanged |
| Renaissance Technologies LLC | 0 | $0 | 0.00% | −722,390−100.0% | Sold out |
| Vanguard Group Inc | 0 | $0 | 0.00% | −378,677−100.0% | Sold out |
| Northern Trust Corp | 0 | $0 | 0.00% | −171,110−100.0% | Sold out |
| Geode Capital Management, LLC | 0 | $0 | 0.00% | −130,774−100.0% | Sold out |
| BlackRock Inc. | 0 | $0 | 0.00% | −109,531−100.0% | Sold out |
| Two Sigma Securities, LLC | 0 | $0 | 0.00% | −81,303−100.0% | Sold out |
| State Street Corp | 0 | $0 | 0.00% | −68,247−100.0% | Sold out |
| Price T Rowe Associates Inc | 0 | $0 | 0.00% | −61,200−100.0% | Sold out |
| Millennium Management LLC | 0 | $0 | 0.00% | −58,579−100.0% | Sold out |
| Cambridge Investment Research Advisors, Inc. | 0 | $0 | 0.00% | −59,825−100.0% | Sold out |
| CI Private Wealth, LLC | 0 | $0 | 0.00% | −43,350−100.0% | Sold out |
| Ergoteles LLC | 0 | $0 | 0.00% | −28,325−100.0% | Sold out |
| Tower Research Capital LLC (TRC) | 0 | $0 | 0.00% | −29,967−100.0% | Sold out |
| Advisor Group Holdings, Inc. | 0 | $0 | 0.00% | −30,300−100.0% | Sold out |
| Bell & Brown Wealth Advisors, LLC | 0 | $0 | 0.00% | −17,000−100.0% | Sold out |
| United Capital Management of KS, Inc. | 0 | $0 | 0.00% | −15,000−100.0% | Sold out |
| HRT Financial LP | 0 | $0 | 0.00% | −24,494−100.0% | Sold out |
| UBS Group AG | 0 | $0 | 0.00% | −2,011−100.0% | Sold out |
| National Bank of Canada | 0 | $0 | 0.00% | −1,000−100.0% | Sold out |
| Archer Investment Corp | 0 | $0 | 0.00% | −300−100.0% | Sold out |
| Wells Fargo & Company | 0 | $0 | 0.00% | −287−100.0% | Sold out |
| Bank of America Corp | 0 | $0 | 0.00% | −100−100.0% | Sold out |
| Morgan Stanley | 0 | $0 | 0.00% | −60−100.0% | Sold out |
| Royal Bank of Canada | 0 | $0 | 0.00% | −217−100.0% | Sold out |
| CWM, LLC | 0 | $0 | 0.00% | −150−100.0% | Sold out |